132 related articles for article (PubMed ID: 38919189)
1. FibroScan as a surveillance marker post-cavopulmonary anastomosis for single-ventricle physiology.
Kumar R; Refai MIM; Thingnam SKS; Kumar R; Rameshbhai NS; Jha N; Ammar A; Sen D; Sehrawat S; Chauhan S
Indian J Thorac Cardiovasc Surg; 2024 Jul; 40(4):419-423. PubMed ID: 38919189
[TBL] [Abstract][Full Text] [Related]
2. Role of Transient Elastography to Stage Fontan-Associated Liver Disease (FALD) in Adults with Single Ventricle Congenital Heart Disease Correction.
Chemello L; Padalino M; Zanon C; Benvegnu' L; Biffanti R; Mancuso D; Cavalletto L
J Cardiovasc Dev Dis; 2021 Sep; 8(10):. PubMed ID: 34677186
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of fibrosis and portal hypertension in Fontan-associated liver disease in children and adults.
Jarasvaraparn C; Thoe J; Rodenbarger A; Masuoka H; Payne RM; Markham LW; Molleston JP
Dig Liver Dis; 2024 Jan; ():. PubMed ID: 38220486
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary ventricle bypass operations].
Alfonso D; Coelho P; Banazol N; Nogueira G; Rebelo M; Freitas I; Trigo C; Pinto F; Fragata I; Fragata J
Rev Port Cir Cardiotorac Vasc; 2006; 13(2):69-74. PubMed ID: 16862259
[TBL] [Abstract][Full Text] [Related]
5. Fontan-Associated Liver Disease: A Review.
Heering G; Lebovics N; Agarwal R; Frishman WH; Lebovics E
Cardiol Rev; 2024 Mar; ():. PubMed ID: 38477576
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Liver and Spleen Stiffness in Patients with Fontan Associated Liver Disease (FALD): A Case Series with Histopathologic Comparison.
Padalino MA; Chemello L; Cavalletto L; Angelini A; Fedrigo M
J Cardiovasc Dev Dis; 2021 Mar; 8(3):. PubMed ID: 33809668
[TBL] [Abstract][Full Text] [Related]
7. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.
Schleiger A; Salzmann M; Kramer P; Danne F; Schubert S; Bassir C; Müller T; Müller HP; Berger F; Ovroutski S
Pediatr Cardiol; 2020 Apr; 41(4):736-746. PubMed ID: 32006084
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive biomarkers of Fontan-associated liver disease.
Emamaullee J; Khan S; Weaver C; Goldbeck C; Yanni G; Kohli R; Genyk Y; Zhou S; Shillingford N; Sullivan PM; Takao C; Detterich J; Kantor PF; Cleveland JD; Herrington C; Ram Kumar S; Starnes V; Badran S; Patel ND
JHEP Rep; 2021 Dec; 3(6):100362. PubMed ID: 34693238
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive Investigations for the Diagnosis of Fontan-Associated Liver Disease in Pediatric and Adult Fontan Patients.
Fidai A; Dallaire F; Alvarez N; Balon Y; Clegg R; Connelly M; Dicke F; Fruitman D; Harder J; Myers K; Patton DJ; Prieur T; Vorhies E; Myers RP; Martin SR; Greenway SC
Front Cardiovasc Med; 2017; 4():15. PubMed ID: 28396861
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Mid-Term Liver Disease After the Fontan Procedure.
Oka N; Miyamoto T; Tomoyasu T; Hayashi H; Miyaji K
Int Heart J; 2020 Sep; 61(5):979-983. PubMed ID: 32921662
[TBL] [Abstract][Full Text] [Related]
11. Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.
Lemmer A; VanWagner L; Gasanova Z; Helmke S; Everson GT; Ganger D
Congenit Heart Dis; 2019 Nov; 14(6):978-986. PubMed ID: 31369200
[TBL] [Abstract][Full Text] [Related]
12. Poor correlation of 2D shear wave elastography and transient elastography in Fontan-associated liver disease: A head-to-head comparison.
Gill M; Mudaliar S; Prince D; Than NN; Cordina R; Majumdar A
JGH Open; 2023 Oct; 7(10):690-697. PubMed ID: 37908293
[TBL] [Abstract][Full Text] [Related]
13. Cardiac MRI-Derived Inferior Vena Cava Cross-Sectional Area Correlates with Measures of Fontan-Associated Liver Disease.
Gunsaulus M; Wang L; Haack L; Christopher A; Feingold B; Squires J; Horslen S; Hoskoppal A; Rose-Felker K; West S; Trucco S; Squires J; Olivieri L; Kreutzer J; Goldstein B; Alsaied T
Pediatr Cardiol; 2024 Apr; 45(4):909-920. PubMed ID: 36454265
[TBL] [Abstract][Full Text] [Related]
14. Fontan-associated liver disease: Diagnosis, surveillance, and management.
de Lange C; Möller T; Hebelka H
Front Pediatr; 2023; 11():1100514. PubMed ID: 36937979
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of Fontan Associated Liver Disease in Childhood and Adolescence.
Hansen JH; Khodami JK; Moritz JD; Rinne K; Voges I; Scheewe J; Kramer HH; Uebing A
Semin Thorac Cardiovasc Surg; 2022; 34(2):642-650. PubMed ID: 33979666
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Fontan-associated Liver Disease and Ethnic Disparities in Long-term Survivors of the Fontan Procedure: A Population-based Study.
Emamaullee J; Martin S; Goldbeck C; Rocque B; Barbetta A; Kohli R; Starnes V
Ann Surg; 2022 Sep; 276(3):482-490. PubMed ID: 35766375
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Fontan-associated liver disease in Japan: Results from a nationwide survey in 2021.
Ohfuji S; Tanaka A; Kogiso T; Kanto T
Hepatol Res; 2024 Mar; ():. PubMed ID: 38526972
[TBL] [Abstract][Full Text] [Related]
18. Abdominal imaging findings in adult patients with Fontan circulation.
Kim TH; Yang HK; Jang HJ; Yoo SJ; Khalili K; Kim TK
Insights Imaging; 2018 Jun; 9(3):357-367. PubMed ID: 29623675
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stiffness in the bidirectional cavopulmonary circulation: The Liver Adult-Pediatric-Congenital-Heart-Disease Dysfunction Study group.
Kutty SS; Zhang M; Danford DA; Hasan R; Duncan KF; Kugler JD; Quiros-Tejeira RE; Kutty S
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):678-684. PubMed ID: 26515874
[TBL] [Abstract][Full Text] [Related]
20. Morphologic Alterations Precede Functional Hepatic Impairment as Determined by
Schleiger A; Kramer P; Sallmon H; Jentsch N; Pileckaite M; Danne F; Schafstedde M; Müller HP; Müller T; Tacke F; Jara M; Stockmann M; Berger F; Ovroutski S
Front Cardiovasc Med; 2021; 8():764009. PubMed ID: 35004881
[No Abstract] [Full Text] [Related]
[Next] [New Search]
